Amazfit watches have stood out in some countries in recent years for their great price-quality ratio, offering better and better designs and health and sports features. In each new generation, we see how they continue to improve, and it seems that they already have in mind what will be the main features of their future watches.
Huami, the company behind Amazfit recently decided to change its name to Zepp Health to become more international. Beyond the name change, the company aims to remain among the best when it comes to health.
Amazfit’s next new features: Electrocardiogram and blood pressure
Mike Yeung, COO of Zepp Health has made some pretty interesting statements on Wareable. In them, he discusses some of the features the company is working on that are pending approval. Zepp Health is collaborating with Alivecor, a manufacturer of electrocardiogram sensors. Although Zepp is working on its algorithm for the sensors, it hopes to gain FDA approval by combining its hardware with Alivecor’s algorithms, which are already of proven quality.
The executive considers that one of the best features that smartwatches currently have is in the field of arrhythmia detection thanks to the capabilities generated by electrocardiograms, but they are looking to go a step further. To do this, they are working on blood pressure and blood glucose meters to be able to perform more advanced analysis during sleep, which today would be Amazfit’s most ambitious goal.
Amazfit’s progress as a company specializing in health watches is worthy of praise, although in the field of smartwatches they still have key aspects to improve beyond health, such as support for third-party applications or the implementation of a mobile payment system that works globally.
